According to Kidney Disease Improving Global Outcome (KDIGO) guidelines, dealing with the complications of CKD (e.g. renal hypertension, hyperlipidemia, proteinuria) is essential, and the use of angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, and statins is common (5). This evidence concerns the gene ACE and kidney disorder.